| INTRODUC TI ON
Coronary ischemic injury induces early vascular repair mechanisms involving mobilization of cells with vascular repairing abilities like Mononuclear Progenitor Cells (MPCs) and production of soluble mediators of inflammation, remodelling and oxidative stress; with potential role as predictors of adverse cardiovascular events in patients with coronary artery disease (CAD) submitted to coronary angioplasty. 1, 2 Intracoronary circulating biomarkers have been postulated as convenient, as they closer reflect vascular damage and repair. 3, 4 However, characterization of coronary biomarkers in human studies has been scanty. 4, 5 This study aimed to explore whether coronary MPCs and vascular injury biomarkers were related to the development of major adverse cardiovascular events (MACEs) and may have prognostic role in patients submitted to coronary angioplasty.
| MATERIAL S AND ME THODS

| Study design
Quasi-experimental, correlational, prospective and obser- Clinical-Demographic data were collected during study enrollment.
| Study population and data collection
High blood pressure, dyslipidemia and Diabetes Mellitus were defined according to JNC8, NCEP/ATPIII and ADA guidelines, respectively. 8,9
| Coronary angiography, stenting and sample collection
Coronary angiography and stenting (everolimus or zotarolimus-eluting stents, mean of 1 stent/vessel; 3 mm diameter, 20 mm length).
Patients received standard dual antiplatelet therapy previous to Percutaneous Coronary Intervention (PCI) and antiplatelet therapy continued for at least 1 year. For blood sampling, 5 mL coronary blood was collected before angioplasty from the closest location to the atheroma plaque. Brachial peripheral blood sample was also collected.
| Determination of circulating MPCs
Blood sample was submitted to density gradient to obtain lymphocytes, which were washed and fixed in 4% paraformaldehyde. 
| Follow up and study endpoints
| Statistical analysis
| RE SULTS
The study population was constituted by 52 patients, mean aged 67.6 years old (31 males, 21 females) whose demographic and clinical characteristics are summarized in Table 1 according to sub-group analysis ( demonstrated prognostic ability for MACEs-free survival ( Figure 1A and B, Kaplan-Meier). Peripheral blood biomarkers showed less significant prognostic performance.
| D ISCUSS I ON
The translational relevance of this study is highlighted by the role of coronary biomarkers related with vascular injury and repair, in the prediction of MACEs and their influence in the prognosis of patients with CAD undergoing angioplasty.
Mobilization of MPCs and increase in adhesion molecules
have been observed in acute cardiovascular events. 1 whereas further clinical relevance of progenitor cells in the mentioned meta-analysis is suggested by risk attenuation in cases of acute heart ischemia and stent re-stenosis. 13 The role of soluble adhesion molecules as predictors of MACE and further adverse outcomes in patients submitted to PCI has been previously hypothesized. 7 Our finding of prognostic ability of sICAM-1 and MMP-9 confirms the clinical usefulness of biomarkers of inflammation and vascular repair in the outcomes of patients with ischaemic heart disease submitted to PCI.
In both cases, coronary circulating MPCs and soluble mediators of vascular injury, showed higher prognostic ability than their peripheral distribution. Only few studies have evaluated the potential of coronary sampling for heart diseases. 
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